Thomas Vos’ Post

View profile for Thomas Vos, graphic

Global Clinical Operations and Clinical Development Specialist at Elixir Associates

🧠 Exciting Breakthrough in Multiple Sclerosis Research- A New Mechanism to Regenerate Myelin? This groundbreaking discovery, published in Cell, highlights the potential of a novel protein function inhibitor, ESI1, to regenerate myelin and restore neurological function. 🔬 Key Insights: ESI1 targets gene silencing in oligodendrocytes, boosting myelin production. Successful preclinical tests in mice and human brain cells suggest potential for human trials! This approach could revolutionize MS treatment and extend to other neurodegenerative conditions. 💡 Implications for the future: Potential to reverse nerve damage in MS and similar disorders. Recovery from brain and spinal injuries. Opens possibilities for combating age-related cognitive decline. #MSresearch #Neuroscience #MedicalBreakthroughs #mutiplesclerosis #myelin #neurodegnerative #regenerativemedicine

Click to read more

Click to read more

To view or add a comment, sign in

Explore topics